Upfront

Jubilant signs agreement with Syngenta

Our News Bureau - Mumbai

Jubilant Organosys has entered into a multi million-Dollar long-term agreement with Syngenta for the supply of pyridines. The new contract starts from early 2008 and covers an extension period of up to five years. During this tenure, Jubilant will continue supplying the products to Syngenta. Pyridines and their derivatives form a part of Jubilant's growth platform under its custom research and manufacturing segment. The company offers both proprietary products and exclusive synthesis options to life science companies in this segment. Currently, Jubilant has the largest integrated manufacturing facilities for these products in India. Recently, Jubilant had expanded its production capacity for pyridines and picolines to 42,000 TPA and this contract would significantly improve the use of the additional capacity. With this multi-year contract and increased capacities Jubilant emerges as the largest player in pyridines worldwide.

"The long term supply agreement for pyridines to Syngenta, is a significant recognition of our global leadership position in pyridines and its derivatives. This is further complemented by the strong relationships and confidence we enjoy with our global customers, who are sector leaders in the pharma and agrochemicals business. We strongly believe that besides providing additional and stable stream of revenue and earnings to our custom research and manufacturing segment, this multi-year contract also helps in further demonstrating and estab-lishing Jubilant's global credentials as a preferred outsourcing partner to life science companies," said Shyam S Bhartia, Chairman and Managing Director. Pyridine and its derivatives represent the high growth area for Jubilant within pharmaceutical and life science products business.